BioSenic S.A. (0R55.L)
0R55.L Stock Price Chart
Explore BioSenic S.A. interactive price chart. Choose custom timeframes to analyze 0R55.L price movements and trends.
0R55.L Company Profile
Discover essential business fundamentals and corporate details for BioSenic S.A. (0R55.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Oct 2022
Employees
12.00
Website
https://www.biosenic.comCEO
Alexia Rieger
Description
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
0R55.L Financial Timeline
Browse a chronological timeline of BioSenic S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 2 Jun 2025
Earnings released on 29 May 2025
Earnings released on 30 Sept 2024
EPS came in at €0.00 , while revenue for the quarter reached €2.69M .
Earnings released on 27 May 2024
EPS came in at -€0.05 , while revenue for the quarter reached €178.00K .
Earnings released on 29 Jun 2023
EPS came in at -€0.17 , while revenue for the quarter reached €182.50K .
Earnings released on 31 Dec 2022
EPS came in at -€0.01 , while revenue for the quarter reached €141.00K .
Earnings released on 29 Jun 2022
EPS came in at -€0.15 .
Dividend declared on 15 Mar 2022
A dividend of €0.29 per share was announced, adjusted to €0.29.
Earnings released on 30 Dec 2021
EPS came in at -€0.40 , while revenue for the quarter reached €1.00M .
Earnings released on 29 Jun 2021
EPS came in at -€0.37 .
Earnings released on 30 Dec 2020
EPS came in at -€0.14 , while revenue for the quarter reached €1.00M .
0R55.L Stock Performance
Access detailed 0R55.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.